-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AMEHoLFt5+CrhgqlfYo1JI5sEFDLf7MfJBvnNGh8j8DUaxxYZfkZ/nLn54fSOvUf ULR8WuVlFpc4EgF4KXy9tQ== 0000950136-96-000486.txt : 19960626 0000950136-96-000486.hdr.sgml : 19960626 ACCESSION NUMBER: 0000950136-96-000486 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960625 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 96584926 BUSINESS ADDRESS: STREET 1: 3233 15TH STREET SOUTH CITY: FARGO STATE: ND ZIP: 58104 BUSINESS PHONE: 7012329575 MAIL ADDRESS: STREET 1: 3233 15TH STREET SOUTH CITY: FARGO STATE: ND ZIP: 58104 COMPANY DATA: COMPANY CONFORMED NAME: KANZER STEVE CENTRAL INDEX KEY: 0001017539 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128325700 3 1 FORM 3 FORM 3 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 _______________________________________________________________________________ 1. Name and Address of Reporting Person Kanzer, Steve - ----------------------------------------------------- (Last) (First) (Middle) 375 Park Avenue - ----------------------------------------------------- (Street) - ----------------------------------------------------- (City) (State) (Zip) _______________________________________________________________________________ 2. Date of Event Requiring Statement (Month/Day/Year) 6/14/96 _______________________________________________________________________________ 3. IRS or Social Security Number of Reporting Person (Voluntary) XXX-XX-XXXX _______________________________________________________________________________ 4. Issuer Name and Ticker of Trading Symbol ImmunoTherapeutics, Inc. _______________________________________________________________________________ 5. Relationship of Reporting Person to Issuer (Check all applicable) [ ] 10% Owner [x] Director [ ] Officer (give title below) [ ] Other (specify below) -------------------------------------------------- -------------------------------------------------- _______________________________________________________________________________ 6. If Amendment, Date of Original (Month/Year) _______________________________________________________________________________ Page 1 FORM 3 (continued)
TABLE I--Non-Derivative Securities Beneficially Owned - ---------------------------------------------------------------------------- 1. 2. 3. 4. - --------------------- -------- ---------- ---------------------- Title of Amount of Ownership Nature of Indirect Security Securities Form:Direct Beneficial (Instr. 4) Beneficially (D) or Ownership Owned Indirect (Instr. 4) (Instr. 4) (I)(Instr. 5) - --------------------- -------- ---------- ----------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Print or Type Responses) Page 2 FORM 3 (continued)
TABLE II--Derivative Securities Beneficially Owned (e.g. puts, calls, warrants, options, convertible securities) - ------------------------------------------------------------------------------------------------------------------------------ 1. 2. 3. 4. 5. 6. - ---------- -------------- -------------- -------- --------- --------- Title and Ownership Date Exer- Amount of Form of cisable and Underlying Deriv- Expiration Securities ative Date (Month/ (Instr. 3 Conver Security: Day/Year) and 4) sion or Direct -------------- -------------- Exercise (D) or Nature of Title of Date Amount Price of Indirect Indirect Derivative Exer- Expir- or Num- Deri- (I) Beneficial Security cis- ation ber of vative (Instr. Ownership (Instr. 4) able Date Title Shares Security 5) (Instr. 5) - ---------- ------- ----- ----- ------ -------- --------- --------- Options to 6/12/96 6/12/206 Common 200,000 $.20 D acquire Stock, 200,000 par value shares or $.001 per Common Stock, share par value $.001 per share
Explanation of Responses: - ----------------------------------------------------- - ----------------------------------------------------- /s/ Steve Kanzer 6/21/96 ---------------------------------------- -------------------- ** Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 3 -----END PRIVACY-ENHANCED MESSAGE-----